Valuation
- Market cap
- 3,000
- Revenue TTM
- $630,000
- Net income TTM
- $-18,000,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -2,857.14%
- Debt to equity
- 0.00
Trading
- Volume
- 5,500
- Avg volume
- 11,886
- Day's range
- $0.00 – $0.00
- Shares out
- 30,740,000
- Stochastic %K
- 50%
- Beta
- 1.09
- Analysts
- —
- Price target
- —
Company profile
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 617 871 2101
- Website
- https://comeralifesciences.com
- Address
- 12 Gill Street, Suite 4650, Woburn, United States
Latest news
No headlines yet.
